Report Detail

Request for Sample of this report

Pharma & Healthcare Global Oligonucleotides Market 2026 by Company, Regions, Type and Application, Forecast to 2032

  • RnM4712586
    • |
  • 29 June, 2026
    • |
  • Global
    • |
  • 140 Pages
    • |
  • GIR
    • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Oligonucleotides market size was valued at US$ 1704 million in 2025 and is forecast to a readjusted size of US$ 3268 million by 2032 with a CAGR of 9.9% during review period.
Oligonucleotides are short nucleic acid polymers used in research, genetic testing and forensics.
Oligonucleotides are usually made up of 13 to 25 nucleotides and are designed to hybridize specifically to DNA or RNA sequences. Solid-phase clinical synthesis is used to manufacture these small bits of nucleic acid for use in polymerase chain reaction (PCR), DNA sequencing, library construction and artificial gene synthesis.
Global Oligonucleotides key players include Integrated DNA Technologies, Agilent, Sigma-aldrich, Eurofins Genomics, L.G.C Biosearch Technologies, etc. Global top five manufacturers hold a share over 45%.
North America is the largest market, with a share over 35%, followed by Europe and China, both have a share over 35percent.
In terms of product, DNA Oligos is the largest segment, with a share over 65%. And in terms of application, the largest application is Research, followed by Pharmaceutical.
This report is a detailed and comprehensive analysis for global Oligonucleotides market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Oligonucleotides market size and forecasts, in consumption value ($ Million), 2021-2032
Global Oligonucleotides market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Oligonucleotides market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Oligonucleotides market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Oligonucleotides
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Oligonucleotides market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Integrated DNA Technologies, Agilent, Sigma-aldrich, Eurofins Genomics, L.G.C Biosearch Technologies, Eurogentec S.A, Nitto Denko Avecia Inc, GenScript, BBI Life Sciences, GeneDesign, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Oligonucleotides market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
DNA Oligos
RNA Oligos
Market segment by Application
Pharmaceutical
Research
Diagnostic
Market segment by players, this report covers
Integrated DNA Technologies
Agilent
Sigma-aldrich
Eurofins Genomics
L.G.C Biosearch Technologies
Eurogentec S.A
Nitto Denko Avecia Inc
GenScript
BBI Life Sciences
GeneDesign
TriLink BioTechnologies
SGS DNA
LC Sciences
Twist Bioscience
Creative Biogene
General Biosystems
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Oligonucleotides product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Oligonucleotides, with revenue, gross margin, and global market share of Oligonucleotides from 2021 to 2026.
Chapter 3, the Oligonucleotides competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Oligonucleotides market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Oligonucleotides.
Chapter 13, to describe Oligonucleotides research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Oligonucleotides by Type
    • 1.3.1 Overview: Global Oligonucleotides Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global Oligonucleotides Consumption Value Market Share by Type in 2025
    • 1.3.3 DNA Oligos
    • 1.3.4 RNA Oligos
  • 1.4 Global Oligonucleotides Market by Application
    • 1.4.1 Overview: Global Oligonucleotides Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Pharmaceutical
    • 1.4.3 Research
    • 1.4.4 Diagnostic
  • 1.5 Global Oligonucleotides Market Size & Forecast
  • 1.6 Global Oligonucleotides Market Size and Forecast by Region
    • 1.6.1 Global Oligonucleotides Market Size by Region: 2021 VS 2025 VS 2032
    • 1.6.2 Global Oligonucleotides Market Size by Region, (2021-2032)
    • 1.6.3 North America Oligonucleotides Market Size and Prospect (2021-2032)
    • 1.6.4 Europe Oligonucleotides Market Size and Prospect (2021-2032)
    • 1.6.5 Asia-Pacific Oligonucleotides Market Size and Prospect (2021-2032)
    • 1.6.6 South America Oligonucleotides Market Size and Prospect (2021-2032)
    • 1.6.7 Middle East & Africa Oligonucleotides Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 Integrated DNA Technologies
    • 2.1.1 Integrated DNA Technologies Details
    • 2.1.2 Integrated DNA Technologies Major Business
    • 2.1.3 Integrated DNA Technologies Oligonucleotides Product and Solutions
    • 2.1.4 Integrated DNA Technologies Oligonucleotides Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Integrated DNA Technologies Recent Developments and Future Plans
  • 2.2 Agilent
    • 2.2.1 Agilent Details
    • 2.2.2 Agilent Major Business
    • 2.2.3 Agilent Oligonucleotides Product and Solutions
    • 2.2.4 Agilent Oligonucleotides Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Agilent Recent Developments and Future Plans
  • 2.3 Sigma-aldrich
    • 2.3.1 Sigma-aldrich Details
    • 2.3.2 Sigma-aldrich Major Business
    • 2.3.3 Sigma-aldrich Oligonucleotides Product and Solutions
    • 2.3.4 Sigma-aldrich Oligonucleotides Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Sigma-aldrich Recent Developments and Future Plans
  • 2.4 Eurofins Genomics
    • 2.4.1 Eurofins Genomics Details
    • 2.4.2 Eurofins Genomics Major Business
    • 2.4.3 Eurofins Genomics Oligonucleotides Product and Solutions
    • 2.4.4 Eurofins Genomics Oligonucleotides Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Eurofins Genomics Recent Developments and Future Plans
  • 2.5 L.G.C Biosearch Technologies
    • 2.5.1 L.G.C Biosearch Technologies Details
    • 2.5.2 L.G.C Biosearch Technologies Major Business
    • 2.5.3 L.G.C Biosearch Technologies Oligonucleotides Product and Solutions
    • 2.5.4 L.G.C Biosearch Technologies Oligonucleotides Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 L.G.C Biosearch Technologies Recent Developments and Future Plans
  • 2.6 Eurogentec S.A
    • 2.6.1 Eurogentec S.A Details
    • 2.6.2 Eurogentec S.A Major Business
    • 2.6.3 Eurogentec S.A Oligonucleotides Product and Solutions
    • 2.6.4 Eurogentec S.A Oligonucleotides Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Eurogentec S.A Recent Developments and Future Plans
  • 2.7 Nitto Denko Avecia Inc
    • 2.7.1 Nitto Denko Avecia Inc Details
    • 2.7.2 Nitto Denko Avecia Inc Major Business
    • 2.7.3 Nitto Denko Avecia Inc Oligonucleotides Product and Solutions
    • 2.7.4 Nitto Denko Avecia Inc Oligonucleotides Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Nitto Denko Avecia Inc Recent Developments and Future Plans
  • 2.8 GenScript
    • 2.8.1 GenScript Details
    • 2.8.2 GenScript Major Business
    • 2.8.3 GenScript Oligonucleotides Product and Solutions
    • 2.8.4 GenScript Oligonucleotides Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 GenScript Recent Developments and Future Plans
  • 2.9 BBI Life Sciences
    • 2.9.1 BBI Life Sciences Details
    • 2.9.2 BBI Life Sciences Major Business
    • 2.9.3 BBI Life Sciences Oligonucleotides Product and Solutions
    • 2.9.4 BBI Life Sciences Oligonucleotides Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 BBI Life Sciences Recent Developments and Future Plans
  • 2.10 GeneDesign
    • 2.10.1 GeneDesign Details
    • 2.10.2 GeneDesign Major Business
    • 2.10.3 GeneDesign Oligonucleotides Product and Solutions
    • 2.10.4 GeneDesign Oligonucleotides Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 GeneDesign Recent Developments and Future Plans
  • 2.11 TriLink BioTechnologies
    • 2.11.1 TriLink BioTechnologies Details
    • 2.11.2 TriLink BioTechnologies Major Business
    • 2.11.3 TriLink BioTechnologies Oligonucleotides Product and Solutions
    • 2.11.4 TriLink BioTechnologies Oligonucleotides Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 TriLink BioTechnologies Recent Developments and Future Plans
  • 2.12 SGS DNA
    • 2.12.1 SGS DNA Details
    • 2.12.2 SGS DNA Major Business
    • 2.12.3 SGS DNA Oligonucleotides Product and Solutions
    • 2.12.4 SGS DNA Oligonucleotides Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 SGS DNA Recent Developments and Future Plans
  • 2.13 LC Sciences
    • 2.13.1 LC Sciences Details
    • 2.13.2 LC Sciences Major Business
    • 2.13.3 LC Sciences Oligonucleotides Product and Solutions
    • 2.13.4 LC Sciences Oligonucleotides Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 LC Sciences Recent Developments and Future Plans
  • 2.14 Twist Bioscience
    • 2.14.1 Twist Bioscience Details
    • 2.14.2 Twist Bioscience Major Business
    • 2.14.3 Twist Bioscience Oligonucleotides Product and Solutions
    • 2.14.4 Twist Bioscience Oligonucleotides Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 Twist Bioscience Recent Developments and Future Plans
  • 2.15 Creative Biogene
    • 2.15.1 Creative Biogene Details
    • 2.15.2 Creative Biogene Major Business
    • 2.15.3 Creative Biogene Oligonucleotides Product and Solutions
    • 2.15.4 Creative Biogene Oligonucleotides Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 Creative Biogene Recent Developments and Future Plans
  • 2.16 General Biosystems
    • 2.16.1 General Biosystems Details
    • 2.16.2 General Biosystems Major Business
    • 2.16.3 General Biosystems Oligonucleotides Product and Solutions
    • 2.16.4 General Biosystems Oligonucleotides Revenue, Gross Margin and Market Share (2021-2026)
    • 2.16.5 General Biosystems Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Oligonucleotides Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of Oligonucleotides by Company Revenue
    • 3.2.2 Top 3 Oligonucleotides Players Market Share in 2025
    • 3.2.3 Top 6 Oligonucleotides Players Market Share in 2025
  • 3.3 Oligonucleotides Market: Overall Company Footprint Analysis
    • 3.3.1 Oligonucleotides Market: Region Footprint
    • 3.3.2 Oligonucleotides Market: Company Product Type Footprint
    • 3.3.3 Oligonucleotides Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Oligonucleotides Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global Oligonucleotides Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global Oligonucleotides Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global Oligonucleotides Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America Oligonucleotides Consumption Value by Type (2021-2032)
  • 6.2 North America Oligonucleotides Market Size by Application (2021-2032)
  • 6.3 North America Oligonucleotides Market Size by Country
    • 6.3.1 North America Oligonucleotides Consumption Value by Country (2021-2032)
    • 6.3.2 United States Oligonucleotides Market Size and Forecast (2021-2032)
    • 6.3.3 Canada Oligonucleotides Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico Oligonucleotides Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe Oligonucleotides Consumption Value by Type (2021-2032)
  • 7.2 Europe Oligonucleotides Consumption Value by Application (2021-2032)
  • 7.3 Europe Oligonucleotides Market Size by Country
    • 7.3.1 Europe Oligonucleotides Consumption Value by Country (2021-2032)
    • 7.3.2 Germany Oligonucleotides Market Size and Forecast (2021-2032)
    • 7.3.3 France Oligonucleotides Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom Oligonucleotides Market Size and Forecast (2021-2032)
    • 7.3.5 Russia Oligonucleotides Market Size and Forecast (2021-2032)
    • 7.3.6 Italy Oligonucleotides Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific Oligonucleotides Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific Oligonucleotides Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific Oligonucleotides Market Size by Region
    • 8.3.1 Asia-Pacific Oligonucleotides Consumption Value by Region (2021-2032)
    • 8.3.2 China Oligonucleotides Market Size and Forecast (2021-2032)
    • 8.3.3 Japan Oligonucleotides Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea Oligonucleotides Market Size and Forecast (2021-2032)
    • 8.3.5 India Oligonucleotides Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia Oligonucleotides Market Size and Forecast (2021-2032)
    • 8.3.7 Australia Oligonucleotides Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America Oligonucleotides Consumption Value by Type (2021-2032)
  • 9.2 South America Oligonucleotides Consumption Value by Application (2021-2032)
  • 9.3 South America Oligonucleotides Market Size by Country
    • 9.3.1 South America Oligonucleotides Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil Oligonucleotides Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina Oligonucleotides Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa Oligonucleotides Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa Oligonucleotides Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa Oligonucleotides Market Size by Country
    • 10.3.1 Middle East & Africa Oligonucleotides Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey Oligonucleotides Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia Oligonucleotides Market Size and Forecast (2021-2032)
    • 10.3.4 UAE Oligonucleotides Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 Oligonucleotides Market Drivers
  • 11.2 Oligonucleotides Market Restraints
  • 11.3 Oligonucleotides Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Oligonucleotides Industry Chain
  • 12.2 Oligonucleotides Upstream Analysis
  • 12.3 Oligonucleotides Midstream Analysis
  • 12.4 Oligonucleotides Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Oligonucleotides. Industry analysis & Market Report on Oligonucleotides is a syndicated market report, published as Global Oligonucleotides Market 2026 by Company, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Oligonucleotides market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo